Connection

Jeffrey Jones to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Jeffrey Jones has written about Drug Administration Schedule.
Jeffrey Jones
Connection Strength
0.134
Drug Administration Schedule
  1. Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial. Lancet Oncol. 2018 01; 19(1):65-75.
    View in: PubMed
    Score: 0.134
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.